Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE
Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE
Active, not recruiting · NCT05995600 · Registry updated 2026-09-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE | Embolism and Thrombosis, antiphospholipid syndrome, autoimmune disease, brain disorder, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, immune system disorder, ischemic stroke, nervous system disorder, stroke disorder, thrombotic disease, transient ischemic attack, vascular disorder | Active, not recruiting | Phase 4 | 2026-09-11 | NCT05995600 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Samjin Pharmaceutical Co., Ltd. | 8 |
| Seoul National University Hospital | 277 |
32 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.